Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Glucotrack (GCTK) Cash from Investing Activities (2016 - 2020)

Glucotrack's Cash from Investing Activities history spans 7 years, with the latest figure at -$7000.0 for Q4 2020.

  • For the quarter ending Q4 2020, Cash from Investing Activities fell 1469.51% year-over-year to -$7000.0, compared with a TTM value of -$53000.0 through Dec 2020, down 130.43%, and an annual FY2025 reading of -$96000.0, up 7.69% over the prior year.
  • Cash from Investing Activities for Q4 2020 was -$7000.0 at Glucotrack, up from -$31000.0 in the prior quarter.
  • The five-year high for Cash from Investing Activities was $8298.0 in Q4 2018, with the low at -$31000.0 in Q3 2020.
  • Average Cash from Investing Activities over 5 years is -$10359.2, with a median of -$7000.0 recorded in 2020.
  • Year-over-year, Cash from Investing Activities surged 93.83% in 2017 and then crashed 1469.51% in 2020.
  • Tracing GCTK's Cash from Investing Activities over 5 years: stood at -$28872.0 in 2016, then skyrocketed by 49.37% to -$14618.0 in 2017, then soared by 156.77% to $8298.0 in 2018, then tumbled by 105.37% to -$446.0 in 2019, then crashed by 1469.51% to -$7000.0 in 2020.
  • Per Business Quant, the three most recent readings for GCTK's Cash from Investing Activities are -$7000.0 (Q4 2020), -$31000.0 (Q3 2020), and -$15000.0 (Q1 2020).